Task X19: Development of Assays and Reagents for Zika Virus Vaccines

任务 X19：寨卡病毒疫苗检测方法和试剂的开发

• 批准号: 9915594
• 负责人: RANDI HORNBACK
• 金额: $ 110.53万
• 依托单位: BATTELLE CENTERS/PUB HLTH RES & EVALUATN
• 依托单位国家: 美国
• 财政年份: 2016
• 资助国家: 美国
• 起止时间: 2016-08-31 至 2020-01-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9915594
• 关键词: Biological; Clinical; Communicable Diseases; Contracts; Development; Feasibility Studies; Phase; Reagent; Sampling; Services; Testing; Toxicity Tests; Vaccines; Zika virus vaccine; assay development; efficacy testing; evaluation/testing; immunogenicity; novel vaccines; product development; safety testing; testing services

The Evaluation and Testing Services (ETS) for Vaccines and Other Biologics for Infectious Diseases contract provides a variety of product development services from early feasibility studies through manufacture of Phase I/II material, including assay development; immunogenicity and efficacy testing; clinical and nonclinical sample testing; and safety and toxicity testing. These services will facilitate the development and introduction of new vaccines and biologics against a wide array of infectious diseases.

传染病合同的疫苗和其他生物制剂的评估和测试服务（ETS）提供了各种产品开发服务，从早期可行性研究到制造I/II期材料，包括分析开发；免疫原性和功效测试；临床和非临床样品测试；以及安全性和毒性测试。 这些服务将有助于开发和引入新的疫苗和生物制剂，以抗各种传染病。